# Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

> **NCT04893291** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Ricerca e Innovazione Cardiovascolare ETS** · enrollment: 1820 (estimated)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis

## Interventions

- **DEVICE:** Everolimus Eluting Stent
- **DEVICE:** Sirolimus Coated Balloon

## Key facts

- **NCT ID:** NCT04893291
- **Lead sponsor:** Fondazione Ricerca e Innovazione Cardiovascolare ETS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-16
- **Primary completion:** 2026-08-30
- **Final completion:** 2030-08-30
- **Target enrollment:** 1820 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893291, "Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04893291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*